A Multicenter, Single-arm, Prospective Phase II Clinical Study of Epalrotokewali Combined With Eribulin, Anlotinib, and Radiotherapy for the Treatment of Patients With Advanced Soft Tissue Sarcoma.
PHASE2
This study intends to enroll patients with advanced soft tissue sarcoma, em...
A Single-center, Single-arm, Phase II Clinical Study of Iparomlimab and Tuvonralimab Injection Combined With Regorafenib in the Treatment of Advanced Second-line or Above Hepatocellular Carcinoma
NA
This study is a prospective, single-center, phase II clinical trial designe...
A Single-Arm, Multicenter, Exploratory Clinical Study of TACE Combined With Iparomlimab and Tuvonralimab Injection (QL1706) and Lenvatinib for Perioperative Treatment of Resectable Hepatocellular Carcinoma
PHASE2
This is a single-arm, multicenter, exploratory clinical study evaluating th...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital with Nanjing Medical University